Pronounce: beks-AIR-oh-teen
Classification: Retinoid
Bexarotene belongs to a class of medications called retinoids. Retinoids are relatives of vitamin A and appear to interfere with genes that control cell growth. The exact way bexarotene works is unknown, but it is believed to inhibit the growth of tumor cells.
Bexarotene gel formulation is applied to the skin. When starting to use this medication, it should be used once every other day for the first week. The frequency should be increased on a weekly basis or as directed by your care provider to once a day, then twice a day, then three times a day, and finally, four times a day.
How to Apply:
Bexarotene gel formulation is available through retail/mail-order pharmacies. Your oncology team will work with your prescription drug plan to identify an in-network retail/mail-order pharmacy for medication distribution.
Store your medication in the original, labeled container at room temperature and in a dry location (unless otherwise directed by your HCP or Pharmacist). Keep containers out of reach of children and pets.
If a caregiver helps you apply the medication, they should consider wearing gloves or dispensing the gel directly into your hand for application. They should always wash their hands before and after touching the medication. Pregnant or nursing women should not touch this medication. Ask your oncology team where to return any unused medication for disposal. Do not throw it in the trash.
Certain cancer medications are only available through specialty pharmacies. If you need to get this medication through a specialty pharmacy, your provider will help you start this process. Where you can fill your prescriptions may also be influenced by your prescription drug coverage. Ask your healthcare provider or pharmacist for assistance in identifying where you can get this medication.
There are a number of things you can do to manage the side effects of bexarotene gel formulation. Talk to your care team about these recommendations. They can help you decide what will work best for you. These are some of the most common or important side effects:
While using this gel, your skin may develop redness, itching, burning, irritation, and scaling in the area of application. Make sure to apply the medication only to the affected areas and avoid healthy skin. Your skin will be more sensitive to the sun, which can result in severe sunburn or rash. Sun sensitivity can last even after you stop taking the medication. Avoid the sun as much as possible, as even a little exposure can cause a burn. Do not use a sunlamp or tanning bed. Wear sunglasses and long sleeves/pants to protect your skin and eyes. Talk to your healthcare provider before using topical lotions and moisturizers as these may interfere with the medication if applied to the same areas.
This medication can make your skin more sensitive to the sun, which can result in severe sunburn or rash. Sun sensitivity can last even after chemotherapy is completed. Avoid the sun between 10-2 pm, when it is strongest. Wear sunscreen (at least SPF 15) every day; wear sunglasses, a hat, and long sleeves/pants to protect your skin and seek out shade whenever possible.
As noted above, exposure of an unborn child to this medication could cause birth defects, so you should not become pregnant or father a child while on this medication. Effective birth control is necessary 1 month before starting the medication, during treatment, and for at least 1 month after treatment. Even if your menstrual cycle stops or you believe you are not producing sperm, you could still be fertile and conceive. You should not breastfeed while using this medication.
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania